Rapidol triple antibiotic first aid ointment recalled over manufacturing deviations
Rapidol Triple Antibiotic First Aid Ointment, 2 oz tubes, is being recalled because of CGMP deviations observed during an FDA inspection. 84 tubes are affected.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall arising from inspection-observed manufacturing deviations with no product defect or consequence described, which fits the Moderate band.
Plain-English summary
Rapidol Triple Antibiotic First Aid Ointment, containing bacitracin zinc 400 units, neomycin sulfate 3.5 mg and polymyxin-B sulfate 5,000 units, net weight 2 oz (57 g) tubes, distributed by Pharmadel LLC of New Castle, Delaware and made in India, is being recalled. The action covers 84 tubes.
The stated reason is CGMP deviations and deficiencies observed during an FDA inspection. The FDA classified the action as Class II. The source does not describe a resulting clinical consequence.
The affected lot is 0004, within expiry. Distribution was USA nationwide.
Consumers who have the affected lot should stop using it and follow the instructions issued by the firm.
The recalled product
- Product
- Rapidol, Triple Antibiotic First Aid Ointment, Bacitracin Zinc 400 units, Neomycin Sulfate 3.5 mg, Polymyxin-B Sulfate 5,000 units, net wt. 2oz (57g) tubes, Distributed by/por: Pharmadel LLC, New Castle, DE 19720, Made in India, UPC 8 10096 77162 9.
- Manufacturer
- Dabur India Limited
- Affected units
- 84
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# 0004
- within expiry
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 14 recalled by Dabur India Limited under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Dabur India Limited
See all →- ModerateMed Pride hydrocortisone cream 1oz tubes recalled over manufacturing deviations
FDA (Drugs) · 2026-06-24
- ModerateLucky Super Soft triple antibiotic ointment recalled over manufacturing deviations
FDA (Drugs) · 2026-06-24
- ModerateLucky Super Soft athlete's foot cream recalled over manufacturing deviations
FDA (Drugs) · 2026-06-24
- ModerateLil Drug Store triple antibiotic ointment recalled over manufacturing deviations
FDA (Drugs) · 2026-06-24
- ModerateCura Hongos clotrimazole cream recalled over manufacturing practice deviations
FDA (Drugs) · 2026-06-24
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateRapidol Triple Antibiotic Ointment Recalled for CGMP Deviations
FDA (Drugs) · 2025-05-28
- ModerateRite Aid First Aid Antibiotic Ointment Recalled for Low Bacitracin Zinc
FDA (Drugs) · 2018-10-24
- ModerateRapidol Hydrocortisone 1% Anti-Itch Cream Recalled for CGMP Deviations
FDA (Drugs) · 2025-05-28
- LowSheffield Triple Antibiotic Ointment Recalled for Stability Failures
FDA (Drugs) · 2013-06-26
- SevereTetraStem Topical Antibiotic Ointment Recalled for Manufacturing Deviations
FDA (Drugs) · 2017-07-12
- ModeratePreferred Pharmaceuticals Recalls Neomycin Ophthalmic Ointment for Quality Control Issues
FDA (Drugs) · 2019-07-31